D'Onofrio Mirko, Beleù Alessandro, De Robertis Riccardo
Department of Radiology, G.B. Rossi Hospital - University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
PhD Programme in Inflammation, Immunity and Cancer, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
Eur Radiol Exp. 2019 Jan 22;3(1):2. doi: 10.1186/s41747-018-0081-2.
Ultrasound (US) is not only an important diagnostic tool for the evaluation of the pancreas, but is also a fundamental imaging technique to guide percutaneous interventions for several pancreatic diseases (fluid aspiration and drainage; invasive diagnosis by means fine-needle aspiration and core-needle biopsy; tumour ablation by radiofrequency, microwaves, irreversible electroporation, cryoablation, and high-intensity focused US). Technical improvements, such as contrast media and fusion imaging, have recently increased precision and safety and reduced procedure-related complications. New treatment US techniques for the ablation of pancreatic tumours, such as contrast-enhanced US and multimodality fusion imaging, have been recently developed and have elicited a growing interest worldwide. The purpose of this article was to review the most up-to-date role of US in percutaneous procedures for pancreatic diseases.
超声（US）不仅是评估胰腺的重要诊断工具，也是指导针对多种胰腺疾病进行经皮介入治疗的基本成像技术（液体抽吸与引流；通过细针穿刺抽吸和粗针活检进行侵入性诊断；通过射频、微波、不可逆电穿孔、冷冻消融和高强度聚焦超声进行肿瘤消融）。诸如造影剂和融合成像等技术改进，最近提高了精准度和安全性，并减少了与操作相关的并发症。用于胰腺肿瘤消融的新型治疗性超声技术，如超声造影和多模态融合成像，最近已得到开发，并在全球引起了越来越多的关注。本文的目的是综述超声在胰腺疾病经皮治疗中的最新作用。
